AbCellera, Vertex partner on next-gen T-cell engagers
The deal adds to a growing streak of partnerships involving new types of T cell engagers and gives Vertex another chance to broaden a business still reliant on cystic fibrosis medicines.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.